Tomoyuki Mizuno

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 40

Top Topics

Clinical Decision Support

Acute Lymphoblastic Leukemia

Acute Kidney Injury

Top Venues

Therapeutic drug monitoring

Clinical pharmacology and therapeutics

Drug metabolism and disposition: the biological fate of chemicals

This page only lists publications with an associated author ORCID identifier.

Publications

Matthijs W van Hoogdalem, Ryota Tanaka, Khaled Abduljalil, Trevor N Johnson, Scott L Wexelblatt, Henry T Akinbi, Alexander A Vinks, Tomoyuki Mizuno
Forecasting Fetal Buprenorphine Exposure through Maternal-Fetal Physiologically Based Pharmacokinetic Modeling. Pharmaceutics 16 (3) (2024)
Iris K Minichmayr, Tomoyuki Mizuno, Srijib Goswami, Richard Wilson Peck, Thomas M Polasek, null null
Recent Advances Addressing the Challenges of Precision Dosing. Clinical pharmacology and therapeutics 116 (3) (2024)
Dahham Alsoud, Dirk Jan A R Moes, Zhigang Wang, Rani Soenen, Zohra Layegh, Murray L Barclay, Tomoyuki Mizuno, Iris K Minichmayr, Ron J Keizer, Sebastian Georg Wicha, Gerrit J Wolbink, Jo Lydie Wilfried Lambert, Severine Vermeire, Annick de Vries, Konstantinos Papamichael, Núria Padullés-Zamora, Erwin Dreesen
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Therapeutic drug monitoring 46 (3) (2024)
Matthijs W van Hoogdalem, Ryota Tanaka, Trevor N Johnson, Alexander A Vinks, Tomoyuki Mizuno
Development and Verification of a Full Physiologically Based Pharmacokinetic Model for Sublingual Buprenorphine in Healthy Adult Volunteers that Accounts for Nonlinear Bioavailability. Drug metabolism and disposition: the biological fate of chemicals 52 (8) (2024)
Matthijs W van Hoogdalem, Ryota Tanaka, Trevor N Johnson, Alexander A Vinks, Tomoyuki Mizuno
Development and Verification of a Full Physiologically Based Pharmacokinetic Model for Sublingual Buprenorphine in Healthy Adult Volunteers that Accounts for Nonlinear Bioavailability. Drug metabolism and disposition: the biological fate of chemicals 52 (8) (2024)
Matthijs W van Hoogdalem, Ryota Tanaka, Khaled Abduljalil, Trevor N Johnson, Scott L Wexelblatt, Henry T Akinbi, Alexander A Vinks, Tomoyuki Mizuno
Forecasting Fetal Buprenorphine Exposure through Maternal-Fetal Physiologically Based Pharmacokinetic Modeling. Pharmaceutics 16 (3) (2024)
Iris K Minichmayr, Tomoyuki Mizuno, Srijib Goswami, Richard Wilson Peck, Thomas M Polasek, null null
Recent Advances Addressing the Challenges of Precision Dosing. Clinical pharmacology and therapeutics (2024)
Matthijs W van Hoogdalem, Ryota Tanaka, Trevor N Johnson, Alexander A Vinks, Tomoyuki Mizuno
Development and verification of a full physiologically-based pharmacokinetic model for sublingual buprenorphine in healthy adult volunteers that accounts for nonlinear bioavailability. Drug metabolism and disposition: the biological fate of chemicals (2024)
Nicole K Wilson, Simon Tremblay, Adele Rike Shields, Ervin Steve Woodle, Raymond T Chung, Alexander A Vinks, Bradley Miyagawa, Tomoyuki Mizuno
Belatacept Removal by Plasmapheresis: Dose Adjustments and Clinical Recommendations. Transplantation direct 10 (8) (2024)
Matthijs W van Hoogdalem, Ryota Tanaka, Trevor N Johnson, Alexander A Vinks, Tomoyuki Mizuno
Development and Verification of a Full Physiologically Based Pharmacokinetic Model for Sublingual Buprenorphine in Healthy Adult Volunteers that Accounts for Nonlinear Bioavailability. Drug metabolism and disposition: the biological fate of chemicals 52 (8) (2024)
Nicole K Wilson, Simon Tremblay, Adele Rike Shields, Ervin Steve Woodle, Raymond T Chung, Alexander A Vinks, Bradley Miyagawa, Tomoyuki Mizuno
Belatacept Removal by Plasmapheresis: Dose Adjustments and Clinical Recommendations. Transplantation direct 10 (8) (2024)
Kathryn E Pavia, Sonya C Tang Girdwood, Kelli Paice, Min Dong, Tomoyuki Mizuno, Peter Tang, Colleen Mangeot, Alexander A Vinks, Jennifer Kaplan
Acute kidney injury is associated with abnormal cefepime exposure among critically ill children and young adults. Pediatric nephrology (Berlin, Germany) (2024)
Matthijs W van Hoogdalem, Ryota Tanaka, Khaled Abduljalil, Trevor N Johnson, Scott L Wexelblatt, Henry T Akinbi, Alexander A Vinks, Tomoyuki Mizuno
Forecasting Fetal Buprenorphine Exposure through Maternal-Fetal Physiologically Based Pharmacokinetic Modeling. Pharmaceutics 16 (3) (2024)
Dahham Alsoud, Dirk Jan A R Moes, Zhigang Wang, Rani Soenen, Zohra Layegh, Murray L Barclay, Tomoyuki Mizuno, Iris K Minichmayr, Ron J Keizer, Sebastian Georg Wicha, Gerrit J Wolbink, Jo Lydie Wilfried Lambert, Severine Vermeire, Annick de Vries, Konstantinos Papamichael, Núria Padullés-Zamora, Erwin Dreesen
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Therapeutic drug monitoring 46 (3) (2024)
Dahham Alsoud, Dirk Jan A R Moes, Zhigang Wang, Rani Soenen, Zohra Layegh, Murray L Barclay, Tomoyuki Mizuno, Iris K Minichmayr, Ron J Keizer, Sebastian Georg Wicha, Gerrit J Wolbink, Jo Lydie Wilfried Lambert, Severine Vermeire, Annick de Vries, Konstantinos Papamichael, Núria Padullés-Zamora, Erwin Dreesen
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Therapeutic drug monitoring (2024)
Matthijs W van Hoogdalem, Ryota Tanaka, Trevor N Johnson, Alexander A Vinks, Tomoyuki Mizuno
Development and Verification of a Full Physiologically Based Pharmacokinetic Model for Sublingual Buprenorphine in Healthy Adult Volunteers that Accounts for Nonlinear Bioavailability. Drug metabolism and disposition: the biological fate of chemicals 52 (8) (2024)
Matthijs W van Hoogdalem, Ryota Tanaka, Khaled Abduljalil, Trevor N Johnson, Scott L Wexelblatt, Henry T Akinbi, Alexander A Vinks, Tomoyuki Mizuno
Forecasting Fetal Buprenorphine Exposure through Maternal-Fetal Physiologically Based Pharmacokinetic Modeling. Pharmaceutics 16 (3) (2024)
Zachary L Taylor, Ethan A Poweleit, Kelli Paice, Katherine M Somers, Kathryn Pavia, Alexander A Vinks, Nieko C Punt, Tomoyuki Mizuno, Sonya C Tang Girdwood
Tutorial on Model Selection and Validation of Model Input into Precision Dosing Software for Model-Informed Precision Dosing. CPT: pharmacometrics & systems pharmacology (2023)
Ethan A Poweleit, Alexander A Vinks, Tomoyuki Mizuno
Artificial Intelligence and Machine Learning Approaches to Facilitate Therapeutic Drug Management and Model-Informed Precision Dosing. Therapeutic drug monitoring (2023)
Ethan A Poweleit, Alexander A Vinks, Tomoyuki Mizuno
Artificial Intelligence and Machine Learning Approaches to Facilitate Therapeutic Drug Management and Model-Informed Precision Dosing. Therapeutic drug monitoring 45 (2) (2023)
Yuko Shimamoto, Keizo Fukushima, Tomoyuki Mizuno, Hajime Ichikawa, Kenichi Kurosaki, Shinichiro Maeda, Masahiro Okuda
Model-informed vancomycin dosing optimization to address delayed renal maturation in infants and young children with critical congenital heart disease. Clinical pharmacology and therapeutics (2023)
Ethan A Poweleit, Alexander A Vinks, Tomoyuki Mizuno
Artificial Intelligence and Machine Learning Approaches to Facilitate Therapeutic Drug Management and Model-Informed Precision Dosing. Therapeutic drug monitoring 45 (2) (2023)
Alexandra Power-Hays, Min Dong, Nieko C Punt, Tomoyuki Mizuno, Luke R Smart, Alexander A Vinks, Russell E Ware
Rationale, development, and validation of HdxSim, a clinical decision support tool for model-informed precision dosing (MIPD) of hydroxyurea for children with sickle cell anemia. Clinical pharmacology and therapeutics (2023)
Bradley Miyagawa, Danielle Lazear, David K Hooper, Alexander A Vinks, Tomoyuki Mizuno
Model-Informed Estimation of Acutely Decreased Tacrolimus Clearance and Subsequent Dose Individualization in a Pediatric Renal Transplant Patient With Posterior Reversible Encephalopathy Syndrome. Therapeutic drug monitoring (2023)
Ethan A Poweleit, Alexander A Vinks, Tomoyuki Mizuno
Artificial Intelligence and Machine Learning Approaches to Facilitate Therapeutic Drug Management and Model-Informed Precision Dosing. Therapeutic drug monitoring 45 (2) (2023)
Bradley Miyagawa, Danielle Lazear, David K Hooper, Alexander A Vinks, Tomoyuki Mizuno
Model-informed Estimation of Acutely Decreased Tacrolimus Clearance and Subsequent Dose Individualization in a Pediatric Renal Transplant Patient with Posterior Reversible Encephalopathy Syndrome. Therapeutic drug monitoring (2022)
Ruben J Colman, Tomoyuki Mizuno, Keizo Fukushima, David B Haslam, Jeffrey S Hyams, Brendan Boyle, Joshua D Noe, Geert R A M D'Haens, Johan E Van Limbergen, Kelly Chun, Jane Yang, Lee A Denson, Nicholas J Ollberding, Alexander A Vinks, Phillip Paul Minar
Real world population pharmacokinetic study in children and young adults with inflammatory bowel disease discovers novel blood and stool microbial predictors of vedolizumab clearance. Alimentary pharmacology & therapeutics (2022)
Tomoyuki Mizuno, Brooks T McPhail, Suyog Kamatkar, Scott Wexelblatt, Laura Ward, Uwe Christians, Henry T Akinbi, Alexander A Vinks
Physiologic Indirect Response Modeling to Describe Buprenorphine Pharmacodynamics in Newborns Treated for Neonatal Opioid Withdrawal Syndrome. Clinical pharmacokinetics 60 (2) (2021)
Matthijs W van Hoogdalem, Trevor N Johnson, Brooks T McPhail, Suyog Kamatkar, Scott L Wexelblatt, Laura P Ward, Uwe Christians, Henry T Akinbi, Alexander A Vinks, Tomoyuki Mizuno
Physiologically-Based Pharmacokinetic Modeling to Investigate the Effect of Maturation on Buprenorphine Pharmacokinetics in Newborns with Neonatal Opioid Withdrawal Syndrome. Clinical pharmacology and therapeutics (2021)
Ruben J Colman, Ye Xiong, Tomoyuki Mizuno, Jeffrey S Hyams, Joshua D Noe, Brendan Boyle, Geert R D'Haens, Johan E Van Limbergen, Kelly Chun, Jane Yang, Michael J Rosen, Lee A Denson, Alexander A Vinks, Phillip Paul Minar
Antibodies-to-infliximab accelerate clearance while dose intensification reverses immunogenicity and recaptures clinical response in paediatric Crohn's disease. Alimentary pharmacology & therapeutics 55 (5) (2021)
Tomoyuki Mizuno, Min Dong, Zachary L Taylor, Laura B Ramsey, Alexander A Vinks
Clinical implementation of pharmacogenetics and model-informed precision dosing to improve patient care. British journal of clinical pharmacology (2020)
Karen D Wright, Xiaopan Yao, Wendy B London, Pei-Chi Kao, Lia Gore, Stephen Hunger, Russ Geyer, Kenneth J Cohen, Jeffrey C Allen, Howard M Katzenstein, Amy Smith, Jessica Boklan, Kellie Nazemi, Tanya Trippett, Matthias A Karajannis, Cynthia Herzog, Joseph Destefano, Jennifer Direnzo, Jay Pietrantonio, Lianne Greenspan, Danielle Cassidy, Debra Schissel, John Perentesis, Mitali Basu, Tomoyuki Mizuno, Alexander A Vinks, Sanjay P Prabhu, Susan N Chi, Mark W Kieran
A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma. Pediatric blood & cancer 68 (2) (2020)
Matthijs W van Hoogdalem, Chie Emoto, Tsuyoshi Fukuda, Tomoyuki Mizuno, Parinda A Mehta, Alexander A Vinks
Population pharmacokinetic modelling of busulfan and the influence of body composition in paediatric Fanconi anaemia patients. British journal of clinical pharmacology 86 (5) (2020)
Zachary L Taylor, Tomoyuki Mizuno, Nieko C Punt, Balaji Baskaran, Adriana Navarro Sainz, William Shuman, Nicholas Felicelli, Alexander A Vinks, Jesper Heldrup, Laura B Ramsey
MTXPK.org: A Clinical Decision Support Tool Evaluating High-Dose Methotrexate Pharmacokinetics to Inform Post-Infusion Care and Use of Glucarpidase. Clinical pharmacology and therapeutics 108 (3) (2020)
Matthijs W van Hoogdalem, Brooks T McPhail, David Hahn, Scott L Wexelblatt, Henry T Akinbi, Alexander A Vinks, Tomoyuki Mizuno
Pharmacotherapy of neonatal opioid withdrawal syndrome: a review of pharmacokinetics and pharmacodynamics. Expert opinion on drug metabolism & toxicology 17 (1) (2020)
Tomoyuki Mizuno, Katja M Gist, Zhiqian Gao, Michael F Wempe, Jeffrey Alten, David S Cooper, Stuart L Goldstein, Alexander A Vinks
Developmental Pharmacokinetics and Age-Appropriate Dosing Design of Milrinone in Neonates and Infants with Acute Kidney Injury Following Cardiac Surgery. Clinical pharmacokinetics 58 (6) (2020)
Laura B Ramsey, Tomoyuki Mizuno, Alexander A Vinks, Maureen M O'Brien
Delayed methotrexate clearance in patients with acute lymphoblastic leukemia concurrently receiving dasatinib. Pediatric blood & cancer 66 (5) (2019)
David Hahn, Chie Emoto, Joshua C Euteneuer, Tomoyuki Mizuno, Alexander A Vinks, Tsuyoshi Fukuda
Influence of OCT1 Ontogeny and Genetic Variation on Morphine Disposition in Critically Ill Neonates: Lessons From PBPK Modeling and Clinical Study. Clinical pharmacology and therapeutics 105 (3) (2018)
Alexander A Boucher, Tomoyuki Mizuno, Alexander A Vinks, Stuart L Goldstein, Greg M Tiao, James I Geller
Dose modifications and pharmacokinetics of adjuvant cisplatin monotherapy while on hemodialysis for patients with hepatoblastoma. Pediatric blood & cancer 66 (1) (2018)
Raymond T Chung, Alexander A Vinks, Tsuyoshi Fukuda, Tomoyuki Mizuno, Eileen C King, Yuanshu Zou, Wenlei Jiang, Ervin Steve Woodle, Simon Tremblay, Jelena Klawitter, Jost Klawitter, Uwe Christians
Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial. PLoS medicine 14 (11) (2017)